Publication | Open Access
Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica
296
Citations
7
References
2014
Year
This study provides Class IV evidence that in patients with NMO, TCZ reduces relapse rate, neuropathic pain, and fatigue.
| Year | Citations | |
|---|---|---|
Page 1
Page 1